135 related articles for article (PubMed ID: 37750222)
1. Locoregional recurrence in triple negative breast cancer: past, present, and future.
Tran J; Thaper A; Lopetegui-Lia N; Ali A
Expert Rev Anticancer Ther; 2023; 23(10):1085-1093. PubMed ID: 37750222
[TBL] [Abstract][Full Text] [Related]
2. Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype.
McGuire A; Lowery AJ; Kell MR; Kerin MJ; Sweeney KJ
Ann Surg Oncol; 2017 Oct; 24(11):3124-3132. PubMed ID: 28755141
[TBL] [Abstract][Full Text] [Related]
3. Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients.
Wang J; Luo J; Jin K; Wang X; Yang Z; Ma J; Mei X; Wang X; Zhou Z; Yu X; Chen X; Guo X
Cancer Med; 2020 Apr; 9(7):2427-2434. PubMed ID: 32048817
[TBL] [Abstract][Full Text] [Related]
4. Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis.
Perez CA; Zumsteg ZS; Gupta G; Morrow M; Arnold B; Patil SM; Traina TA; Robson ME; Wen YH; McCormick B; Powell SN; Ho AY
Breast Cancer Res Treat; 2013 Jun; 139(2):497-506. PubMed ID: 23645006
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conserving therapy.
Bhatti AB; Khan AI; Siddiqui N; Muzaffar N; Syed AA; Shah MA; Jamshed A
Asian Pac J Cancer Prev; 2014; 15(6):2577-81. PubMed ID: 24761867
[TBL] [Abstract][Full Text] [Related]
6. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
[TBL] [Abstract][Full Text] [Related]
7. Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer.
Zumsteg ZS; Morrow M; Arnold B; Zheng J; Zhang Z; Robson M; Traina T; McCormick B; Powell S; Ho AY
Ann Surg Oncol; 2013 Oct; 20(11):3469-76. PubMed ID: 23686101
[TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of outcome after treatment for triple-negative and non-triple-negative breast cancer.
Joyce DP; Murphy D; Lowery AJ; Curran C; Barry K; Malone C; McLaughlin R; Kerin MJ
Surgeon; 2017 Oct; 15(5):272-277. PubMed ID: 28277293
[TBL] [Abstract][Full Text] [Related]
9. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
[TBL] [Abstract][Full Text] [Related]
10. Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial.
Mukhtar RA; Chau H; Woriax H; Piltin M; Ahrendt G; Tchou J; Yu H; Ding Q; Dugan CL; Sheade J; Crown A; Carr M; Wong J; Son J; Yang R; Chan T; Terando A; Alvarado M; Ewing C; Tonneson J; Tamirisa N; Gould R; Singh P; Godellas C; Larson K; Chiba A; Rao R; Sauder C; Postlewait L; Lee MC; Symmans WF; Esserman LJ; Boughey JC;
Ann Surg; 2023 Sep; 278(3):320-327. PubMed ID: 37325931
[TBL] [Abstract][Full Text] [Related]
11. Triple-negative breast cancer is not a contraindication for breast conservation.
Adkins FC; Gonzalez-Angulo AM; Lei X; Hernandez-Aya LF; Mittendorf EA; Litton JK; Wagner J; Hunt KK; Woodward WA; Meric-Bernstam F
Ann Surg Oncol; 2011 Oct; 18(11):3164-73. PubMed ID: 21947595
[TBL] [Abstract][Full Text] [Related]
12. Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.
Kindts I; Buelens P; Laenen A; Van Limbergen E; Janssen H; Wildiers H; Weltens C
Breast; 2017 Apr; 32():18-25. PubMed ID: 28012411
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy.
Kim S; Park HS; Kim JY; Ryu J; Park S; Kim SI
Yonsei Med J; 2016 Sep; 57(5):1192-8. PubMed ID: 27401651
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy.
Weksberg DC; Allen PK; Hoffman KE; Litton JK; Strom EA; Shah RR; Kuerer HM; Hunt KK; Buchholz TA; Mittendorf EA
Ann Surg Oncol; 2013 Oct; 20(11):3430-7. PubMed ID: 23720073
[TBL] [Abstract][Full Text] [Related]
15. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
Yagata H; Kajiura Y; Yamauchi H
Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
[TBL] [Abstract][Full Text] [Related]
16. Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype.
Braunstein LZ; Niemierko A; Shenouda MN; Truong L; Sadek BT; Abi Raad R; Wong JS; Punglia RS; Taghian AG; Bellon JR
Breast J; 2015; 21(2):161-7. PubMed ID: 25559656
[TBL] [Abstract][Full Text] [Related]
17. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
[TBL] [Abstract][Full Text] [Related]
18. Breast-conserving therapy for triple-negative breast cancer.
Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
[TBL] [Abstract][Full Text] [Related]
19. Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis.
Wang J; Xie X; Wang X; Tang J; Pan Q; Zhang Y; Di M
Surg Oncol; 2013 Dec; 22(4):247-55. PubMed ID: 24144808
[TBL] [Abstract][Full Text] [Related]
20. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype.
Lowery AJ; Kell MR; Glynn RW; Kerin MJ; Sweeney KJ
Breast Cancer Res Treat; 2012 Jun; 133(3):831-41. PubMed ID: 22147079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
